Communities across the globe commemorated World AIDS Day, reaffirming a commitment to end an epidemic that has killed more ...

HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...

Dr. Malebranche, who serves as the Senior Director of Global HIV Medical Affairs at Gilead Sciences, joined the conversation ...

Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...

The Centers for Disease Control and Prevention first used the term “AIDS” on Sept. 24, 1982, more than a year after the first ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

In the United States, HIV continues to be a significant cause of morbidity and mortality. In 2023, more than 39,000 people were diagnosed with HIV, and approximately 4,500 people died from causes ...

SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to undetectable levels. As a result, by taking a single daily dose of an ...

Major changes are underway at the Centers for Disease Control and Prevention (CDC) following President Trump’s and Health and Human Services (HHS) Secretary Robert Kennedy Jr.’s dismissal of director ...

The Trump administration's battering of global HIV programs has garnered much attention, but infectious disease experts are concerned about HIV prevention at home, too. The CDC's Division of HIV ...

The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...